A US Congressional report summarizing issues facing the dietary supplement industry – signaling a possible legislative hearing on the horizon – notes various “limitations” in the US Food and Drug Administration’s current authority over supplements.
The Congressional Research Service (CRS), which works exclusively with US Congress to provide policy and legal analysis to House and Senate committee members, published the 28-page report, “Regulation of Dietary...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?